AI assistant
Sending…
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015
Apr 30, 2015
31580_dirs_2015-04-30_5cbef38f-0f7f-4819-af88-58036d69d879.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-04-28
Reporting Person: MARAGANORE JOHN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-28 | Common stock | G | 515 | $0.00 | Disposed | 50174 | Direct |
Footnotes
F1: Reflects a gift of shares from the reporting person to Brigham and Women's Hopsital.
More from AGIOS PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3